From imbalance to impairment: the central role of reactive oxygen species in oxidative stress-induced disorders and therapeutic exploration

S Afzal, AS Abdul Manap, A Attiq… - Frontiers in …, 2023 - frontiersin.org
Increased production and buildup of reactive oxygen species (ROS) can lead to various
health issues, including metabolic problems, cancers, and neurological conditions. Our …

A triterpenoid lupeol as an antioxidant and anti-neuroinflammatory agent: impacts on oxidative stress in Alzheimer's disease

JS Park, IU Rehman, K Choe, R Ahmad, HJ Lee… - Nutrients, 2023 - mdpi.com
Alzheimer's disease (AD) is the most common neurodegenerative disease illustrated by
neuronal dysfunctions, leading to memory weaknesses and personality changes mostly in …

Serum proteomics reveal APOE-ε4-dependent and APOE-ε4-independent protein signatures in Alzheimer's disease

EA Frick, V Emilsson, T Jonmundsson… - Nature Aging, 2024 - nature.com
A deeper understanding of the molecular processes underlying late-onset Alzheimer's
disease (LOAD) could aid in biomarker and drug target discovery. Using high-throughput …

Molecular mechanisms in Alzheimer's disease and related potential treatments such as structural target convergence of antibodies and simple organic molecules

N Oumata, K Lu, Y Teng, C Cavé, Y Peng… - European Journal of …, 2022 - Elsevier
The amyloid cascade is the most frequently accepted hypothesis of Alzheimer's Disease
(AD). According to this hypothesis, the formation of plaques precedes the appearance of …

Potential therapeutic effects and pharmacological evidence of sinomenine in central nervous system disorders

H Hong, X Lu, Q Lu, C Huang, Z Cui - Frontiers in Pharmacology, 2022 - frontiersin.org
Sinomenine is a natural compound extracted from the medicinal plant Sinomenium acutum.
Its supplementation has been shown to present benefits in a variety of animal models of …

Targeting protein kinases for the treatment of Alzheimer's disease: recent progress and future perspectives

Z Li, B Yin, S Zhang, Z Lan, L Zhang - European Journal of Medicinal …, 2023 - Elsevier
Alzheimer's disease (AD) is a serious neurodegenerative disease characterized by memory
impairment, mental retardation, impaired motor balance, loss of self-care and even death …

Genetic and epigenetic targets of natural dietary compounds as anti-Alzheimer's agents

WO Castillo-Ordoñez, N Cajas-Salazar… - Neural regeneration …, 2024 - journals.lww.com
Alzheimer's disease is a progressive neurodegenerative disorder and the most common
cause of dementia that principally affects older adults. Pathogenic factors, such as oxidative …

The impact of intermittent hypoxia on metabolism and cognition

R Shobatake, H Ota, N Takahashi, S Ueno… - International Journal of …, 2022 - mdpi.com
Intermittent hypoxia (IH), one of the primary pathologies of sleep apnea syndrome (SAS),
exposes cells throughout the body to repeated cycles of hypoxia/normoxia that result in …

Contribution of amyloid deposition from oligodendrocytes in a mouse model of Alzheimer's disease

A Ishii, JA Pathoulas, O MoustafaFathy Omar… - Molecular …, 2024 - Springer
Background The accumulation of β-amyloid (Aβ) peptides into insoluble plaques is an early
pathological feature of Alzheimer's disease (AD). BACE1 is the sole β-secretase for Aβ …

BACE1 Inhibitors for Alzheimer's Disease: Current Challenges and Future Perspectives

JRM Coimbra, R Resende… - Journal of …, 2024 - journals.sagepub.com
Disease-modifying therapies (DMT) for Alzheimer's disease (AD) are highly longed-for. In
this quest, anti-amyloid therapies take center stage supported by genetic facts that highlight …